BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1816240)

  • 1. Plasmapheresis in acute multiple sclerosis: rationale and results.
    Dau PC
    J Clin Apher; 1991; 6(4):200-4. PubMed ID: 1816240
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmapheresis in acute attacks of multiple sclerosis: the cons.
    Rostami AM
    J Clin Apher; 1991; 6(4):205-6. PubMed ID: 1816241
    [No Abstract]   [Full Text] [Related]  

  • 3. Relapse of multiple sclerosis following acute allergic reactions to plasma during plasmapheresis.
    Wirguin I; Shinar E; Abramsky O
    J Neurol; 1989 Jan; 236(1):62-3. PubMed ID: 2915232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
    Hauser SL; Fosburg M; Kevy S; Weiner HL
    Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasmapheresis in acute phase of multiple sclerosis and neuromyelitis optica].
    Matsuo H
    Nihon Rinsho; 2014 Nov; 72(11):1999-2002. PubMed ID: 25518384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasmapheresis in acute phase of multiple sclerosis].
    Matsuo H
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():191-5. PubMed ID: 26480699
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic apheresis in multiple sclerosis].
    Nomura K
    Nihon Rinsho; 2003 Aug; 61(8):1388-95. PubMed ID: 12962028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphocyto-plasmapheresis for relapsing multiple sclerosis].
    Jyoichi T; Kamegai M; Noda Y; Shimojo S; Miyahara T
    Rinsho Shinkeigaku; 1986 Sep; 26(9):907-9. PubMed ID: 3791770
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current therapy of multiple sclerosis. Are there indications for plasmapheresis?].
    Schönbeck S; Hohlfeld R
    Nervenarzt; 1992 Feb; 63(2):116-9. PubMed ID: 1314334
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of therapeutic plasmapheresis in the exacerbation period of multiple sclerosis].
    Neretin VIa; Kir'iakova VA; Sapfirova VA; Ivanov MI; Volkova EK
    Sov Med; 1988; (2):86-9. PubMed ID: 3388103
    [No Abstract]   [Full Text] [Related]  

  • 11. Scientific overview of multiple sclerosis.
    Walker JE
    Prog Clin Biol Res; 1982; 106():233-7. PubMed ID: 6757942
    [No Abstract]   [Full Text] [Related]  

  • 12. Persistence of antibrain antibodies in cerebrospinal fluid during plasmapheresis for multiple sclerosis.
    Ryberg B; Pirskanen R
    Br Med J (Clin Res Ed); 1985 Sep; 291(6499):850-1. PubMed ID: 2996688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmapheresis in multiple sclerosis: preliminary study.
    Weiner HL; Dawson DM
    Neurology; 1980 Oct; 30(10):1029-33. PubMed ID: 7191492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasmapheresis and immunosuppressive drugs in the treatment of multiple sclerosis].
    Cendrowski W
    Neurol Neurochir Pol; 1984; 18(3):259-62. PubMed ID: 6390235
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasmapheresis in multiple sclerosis: preliminary findings.
    Dau PC; Petajan JH; Johnson KP; Panitch HS; Bornstein MB
    Neurology; 1980 Oct; 30(10):1023-8. PubMed ID: 6448360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiological changes of inflammatory syndrome in multiple sclerosis after instituting therapeutic plasmapheresis.
    Vlaic S; Poalelungi V; Bălăeţ M; Purcărea VL; Bălăeţ C; Coculescu BI
    J Med Life; 2017; 10(1):50-53. PubMed ID: 28255377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood multiple sclerosis treated with plasmapheresis.
    Takahashi I; Sawaishi Y; Takeda O; Enoki M; Takada G
    Pediatr Neurol; 1997 Jul; 17(1):83-7. PubMed ID: 9308985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute and reversible worsening of multiple sclerosis treated with plasmapheresis. A form of Uhthoff symptom?].
    Muchnik S; Jáuregui WO; Mazía C
    Medicina (B Aires); 1985; 45(2):207-8. PubMed ID: 3841931
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone.
    Tindall RS; Walker JE; Ehle AL; Near L; Rollins J; Becker D
    Neurology; 1982 Jul; 32(7):739-43. PubMed ID: 7201110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasmapheresis in the treatment of neurologic disorders].
    Szobor A; Fornádi L; Vájlok M
    Orv Hetil; 1988 Jan; 129(3):119-23. PubMed ID: 3281091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.